Abstract
Bazex syndrome is a rare cutaneous paraneoplastic phenomenon not previously reported in association with neuroendocrine tumours. We describe a patient who responded well to treatment with octreotide.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bazex A., Griffiths A. Acrokeratosis paraneoplastica--a new cutaneous marker of malignancy. Br J Dermatol. 1980 Sep;103(3):301–306. doi: 10.1111/j.1365-2133.1980.tb07248.x. [DOI] [PubMed] [Google Scholar]
- Bolognia J. L., Brewer Y. P., Cooper D. L. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) 1991 Jul;70(4):269–280. doi: 10.1097/00005792-199107000-00004. [DOI] [PubMed] [Google Scholar]
- Brenner S., Brayer M., Topilsky M. Acrokeratosis paraneoplastica (Basex) in a patient with bronchial carcinoid tumor. J Am Acad Dermatol. 1987 Sep;17(3):517–518. doi: 10.1016/s0190-9622(87)80379-1. [DOI] [PubMed] [Google Scholar]
- Camisa C. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology. Arch Dermatol. 1989 Mar;125(3):407–412. [PubMed] [Google Scholar]
- Handfield-Jones S. E., Matthews C. N., Ellis J. P., Das K. B., McGibbon D. H. Acrokeratosis paraneoplastica of Bazex. J R Soc Med. 1992 Sep;85(9):548–550. doi: 10.1177/014107689208500913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Donnell L. J., Farthing M. J. Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases. Gut. 1989 Sep;30(9):1165–1172. doi: 10.1136/gut.30.9.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]